Ghrelin receptor agonists for the treatment of cachexia

The present invention provides a compound of the present invention, salts capable of their pharmaceutically acceptable, or a pharmaceutical composition containing them, to be used in the manufacture of a medicament for the treatment of cachexia. Further, the present invention is the compound, or a pharmaceutical composition comprising them to a method of treating a disease comprising administering to a human or animal. The present invention, the compound, salt can be their pharmaceutically acceptable, or a pharmaceutical composition containing them, to the use of the combination of the one or more second active agents. Furthermore, the present invention is used in the treatment of such diseases, the compounds of the present invention, or a pharmaceutical composition and a kit comprising a pharmaceutically acceptable salt thereof.